Nov Inc NOV

$20.55 +0.36 (1.78%)

Valuation

Market cap
7,044,005,000
Revenue TTM
$8,744,000,000
Net income TTM
$145,000,000
PE ratio
31.80
Forward PE
19.03
Profit margin
1.66%
Debt to equity
0.27

Trading

Volume
4,636,233
Avg volume
3,300,226
Day's range
$20.18 – $20.57
Shares out
356,478,000
Stochastic %K
98%
Beta
0.97
Analysts
Sell
Price target
$22.53

Price

Company profile

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates in two segments, Energy Equipment, and Energy Products and Services. The Energy Products and Services segment offers drill bits and borehole enlargement products; independent drilling and inter...

Show more

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates in two segments, Energy Equipment, and Energy Products and Services. The Energy Products and Services segment offers drill bits and borehole enlargement products; independent drilling and intervention downhole tools equipment; frac plugs, frac sleeves, toe initiation burst port systems, and recyclable setting tools; electric submersible pumps, high viscosity pumps, and surface pumps; tubular coating and inspection services for drill-pipe and other oil country tubular goods; solids control and waste management equipment and services; data and digital solutions; precision-engineered drill pipe and drill-stem equipment; connectors and integral thread solutions, including conductor strings, surface casing, and liners; and composite pipe, tanks, and structures. Its Energy Equipment segment provides drilling equipment, such as land rigs, complete offshore drilling packages, and rig components; capital equipment, related consumables, and digital products for hydraulic stimulation, coiled tubing, and wireline services; marine and construction solutions; processing solutions for the separation and treatment of oil, gas, solids, seawater, and produced water production; flexible subsea pipe systems; cavity pumps, specialized mixers and heat exchangers; and reciprocating, multistage, and progressive cavity pumps, midstream products, including closures, transfer pumps, chokes and valves, as well as artificial lift support systems that include production BOPs and stuffing boxes. The company was formerly known as National Oilwell Varco, Inc. and changed its name to NOV Inc. in January 2021. NOV Inc. was founded in 1862 and is based in Houston, Texas.

Industry
Oil & Gas Equipment & Services
Sector
Energy
Phone
346 223 3000
Website
https://www.nov.com
Address
10353 Richmond Avenue, Houston, United States

Latest news

Stocktwits

shoc24 Oct 27, 6:05 PM
$NOV reports earnings today after the close. I used Stock Meadow’s earnings dashboard to review its history: NOV has beaten EPS estimates in 2 of its last 8 reports. Analysts expect EPS of $0.25. What are you watching for?
0 replies
Estimize Oct 27, 3:00 PM
$NOV reports after the close, Estimize Consensus +0 EPS and -0.46M Revs compared to WS http://www.estimize.com/nov/fq3-2026?utm_content=pre
0 replies
TechTraderAI Oct 5, 5:02 PM
Bought $ITUB. Sold $NOV (-8.9%). 31% long by 14% short. 11% long Finance, 7% long Consumer Discretionary, 7% long Energy, 4% short Industrials, 3% short Real Estate. https://www.techtrader.ai/wall/?date=1791219458&post=18617
0 replies
Estimize Oct 5, 2:09 PM
Wall St is expecting 0.25 EPS for $NOV Q3 [Reporting 10/27 AMC] http://www.estimize.com/intro/nov?chart=historical&metric_name=eps&utm_cont
0 replies
Estimize Sep 28, 2:09 PM
Wall St is expecting 0.25 EPS for $NOV Q3 [Reporting 10/27 AMC] http://www.estimize.com/intro/nov?chart=historical&metric_name=eps&utm_cont
0 replies
CaptBeer Sep 22, 12:22 PM
Why I still think $AMRN is a good strategic fit for $NOV: “Novo’s own words from CMD yesterday make the strategic case for something like AMRN/Vascepa pretty clear: • ‘We will be more active within business development… [we] have gone shopping’ • Looking to fill gaps in CVD / residual risk areas • Quality of asset first, size second • Disciplined bolt-ons in cardiometabolic adjacencies Approved 25% MACE RRR product that sits perfectly in residual risk + Novo’s new CVD push + tiny market cap = logical opportunistic fit.
2 replies
ConcentratedPositions Sep 21, 1:43 PM
$FET $OIH currently lower than before bombs started dropping… and that’s how i know there’s a lot of juice left to squeeze. You can’t spin this negatively over the next 3 years… pretty interesting to see. But you still gotta pick the right horse. FET crushing the large caps as the business inflects higher $SLB $NOV $BKR
0 replies
ConcentratedPositions Sep 17, 3:42 PM 0 replies